Aberdeen Group’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-16,776
Closed -$552K 960
2020
Q2
$552K Buy
+16,776
New +$552K ﹤0.01% 857